GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » Price-to-Owner-Earnings

Gaush Meditech (HKSE:02407) Price-to-Owner-Earnings : 12.68 (As of May. 26, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech Price-to-Owner-Earnings?

As of today (2024-05-26), Gaush Meditech's share price is HK$18.90. Gaush Meditech's Owner Earnings per Share (TTM) ended in Dec. 2023 was HK$1.49. It's Price-to-Owner-Earnings for today is 12.68.


The historical rank and industry rank for Gaush Meditech's Price-to-Owner-Earnings or its related term are showing as below:

HKSE:02407' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 11.39   Med: 13.59   Max: 24.11
Current: 12.68

During the past 5 years, the highest Price-to-Owner-Earnings of Gaush Meditech was 24.11. The lowest was 11.39. And the median was 13.59.


HKSE:02407's Price-to-Owner-Earnings is ranked better than
78.65% of 281 companies
in the Medical Devices & Instruments industry
Industry Median: 33.36 vs HKSE:02407: 12.68

As of today (2024-05-26), Gaush Meditech's share price is HK$18.90. Gaush Meditech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.28. Therefore, Gaush Meditech's PE Ratio for today is 14.78.

As of today (2024-05-26), Gaush Meditech's share price is HK$18.90. Gaush Meditech's EPS without NRI for the trailing twelve months (TTM) ended in was HK$1.26. Therefore, Gaush Meditech's PE Ratio without NRI for today is 15.05.

During the past 5 years, Gaush Meditech's highest PE Ratio without NRI was 44.40. The lowest was 13.51. And the median was 21.07.


Gaush Meditech Price-to-Owner-Earnings Historical Data

The historical data trend for Gaush Meditech's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gaush Meditech Price-to-Owner-Earnings Chart

Gaush Meditech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - - - 25.32

Gaush Meditech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - 25.32

Competitive Comparison of Gaush Meditech's Price-to-Owner-Earnings

For the Medical Devices subindustry, Gaush Meditech's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gaush Meditech's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Gaush Meditech's Price-to-Owner-Earnings falls into.



Gaush Meditech Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Gaush Meditech's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=18.90/1.49
=12.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gaush Meditech  (HKSE:02407) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Gaush Meditech Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Gaush Meditech (HKSE:02407) Business Description

Traded in Other Exchanges
N/A
Address
No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN
Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.
Executives
Orbimed Advisors Iii Limited 2102 Investment manager
Orbimed Asia Gp Iii, L.p. 2102 Investment manager
Orbimed Asia Partners Iii, L.p. 2102 Investment manager
Gao Tieta 2201 Interest of corporation controlled by you
Gaush Holding Ltd 2101 Beneficial owner
Cuprite Gem Investments Ltd 2101 Beneficial owner
Warburg Pincus (bermuda) Private Equity Gp Ltd. 2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp Llc 2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp, L.p. 2201 Interest of corporation controlled by you
Warburg Pincus China-southeast Asia Ii (cayman), L.p. 2201 Interest of corporation controlled by you
Warburg Pincus Partners Ii (cayman), L.p. 2201 Interest of corporation controlled by you

Gaush Meditech (HKSE:02407) Headlines

No Headlines